Navigation Links
Cancer Diagnostics Universe Discussed in Comprehensive VPG Research Study Published at MarketPublishers.com
Date:8/6/2014

London, UK (PRWEB) August 06, 2014

The market for cancer diagnostics is on the verge of exploding, as the research workers approach key technology advances relating to tumour diagnosis and treatment, discover novel tumour-specific antigens, and also get to the heart of the mystery of the genetic basis of this insidious disease. Over the next five years, the global cancer diagnostics marketplace promises to be a very dynamic and rapidly expanding sphere. Expected advancements in technology will create multiple opportunities for determining genetic susceptibility, identifying specific tumours, and investigating the human body's biological response to cancer therapy and treatment. Furthermore, the upsurge in the ageing human population is anticipated to compound the soaring demand for malignancy assays and the fast-paced market expansion from pole to pole.

Comprehensive study “2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations” prepared by Venture Planning Group (VPG) is now available at MarketPublishers.com.

Report Details:

Title: 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
Published: July, 2014
Pages: 1200
Price: US$ 34,500.00
http://marketpublishers.com/report/diagnostics-diseases/cancer/2014-market-segmentation-analysis-of-global-cancer-diagnostics-industry.html

The research report provides a strategic analysis of key business opportunities in the cancer diagnostics market globally with a focus on the 7 key countries (France, Germany, Italy, Japan, Spain, the UK, and the USA) in the forthcoming years. The report examines trends in the regions covered; reviews current and emerging assays; analyses potential applications of innovative diagnostic technologies; covers sales and market shares of leading suppliers of cancer diagnostic products (by test and country); presents sales and test volume forecasts of leading tumor markers by market segment and country; profiles the dominant players along with potential entrants into the market. A variety of business expansion strategies for suppliers are identified in the research study as well.

Report Scope:

  •         Overview of the global tumour diagnostics market, including 5-year test volume and sales projections by country; market segmentation analysis; the estimated number of laboratories performing respective testing (by country); tumour statistics, etiology and latest developments region-wise.
  •         Up-close look at the opportunities arising including appropriate strategic recommendations.
  •         Thorough study of more than 200 cancer diagnostic tests, current and emerging.
  •     Suppliers’ shares and market shares (by test and country); 5-year test volume and sales forecast data for key tumour markers (by country and market segment).
  •     Comprehensive assessment of instrumentation for cancer testing.
  •     Assessment of modern technologies (including complementing/ competing ones) and their potential applications for cancer diagnostic testing; extensive listings of organisations developing novel tumour diagnostic tests and detection technologies.    
  •         Strategic evaluations of the top suppliers and start-ups that develop new cancer diagnostic products and technologies.

More comprehensive and new market research reports by the publisher can be found at VPG page.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12075850.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology: